Announced
Completed
Synopsis
Astorg Partners, a private equity firm, completed the acquisition of CordenPharma, a pharmaceutical CDMO, from International Chemical Investors Group, a chemical company, for $3.2bn. "The transaction is the result of our thematic sourcing effort in pharma services. We identified the Company as a leading CDMO focused on some of the most promising areas of pharma R&D and with a strong customer focus and unique innovation capabilities," Judith Charpentier, Astorg Partner and Head of Healthcare.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.